Stock listing

NASDAQ:LBRX LB Pharmaceuticals Inc Stock

Home listing (NASDAQ) of LB Pharmaceuticals Inc

Follow LB Pharmaceuticals Inc into a list and get an email when it puts out news.

Share price · NASDAQ:LBRX

$40.06 USD -0.24 (-0.6%)

Close on Nov 18, 2026

Past year +151.6% · daily closes, Nov 18, 2025 – Nov 18, 2026, adjusted for splits
Day range
$38.72 – $41.71 USDNov 18, 2026
Volume
356,411 sharesNov 18, 2026
Market cap
$1.30B USDAt the close on Nov 18, 2026 · price × 32.36M shares outstanding
52-week range
$15.19 – $50.16 USDLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
Traded on an average day
$15.07M USDMedian day 355,391 shares · last 3 months, Aug 18, 2026 – Nov 18, 2026
LB Pharmaceuticals Inc logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:LBRX · Home$40.06 USD-0.24 (-0.6%)356,411$40.31$41.71$38.72$40.30Close on Nov 18, 2026

Daily closes

Last 3 months, Aug 18, 2026 – Nov 18, 2026 · NASDAQ:LBRX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$40.06-0.24-0.6%$40.31$41.71$38.72356,411
$40.30-2.69-6.3%$43.20$44.01$38.83396,092
$42.99-0.020.0%$43.07$43.95$42.08597,257
$43.01+0.55+1.3%$42.66$43.43$41.03330,168
$42.46-2.25-5.0%$44.37$44.37$41.88438,110
$44.71-0.23-0.5%$45.21$45.46$44.30341,759
$44.94-0.18-0.4%$44.38$45.68$43.46377,881
$45.12+3.11+7.4%$43.05$45.77$41.54472,299
$42.01+3.92+10.3%$38.53$42.29$38.52476,193
$38.09-2.76-6.8%$41.01$41.01$38.02354,370
$40.85+0.52+1.3%$41.40$41.40$38.75365,762
$40.33+1.29+3.3%$39.65$41.40$39.15245,821
$39.04-0.66-1.7%$40.56$40.91$38.24466,446
$39.70-0.45-1.1%$40.10$41.24$39.13429,435
$40.15+0.32+0.8%$39.80$40.76$39.23400,678
$39.83+0.19+0.5%$39.53$40.38$38.49201,736
$39.64+0.30+0.8%$39.14$40.35$38.58236,345
$39.34+0.61+1.6%$41.05$41.05$38.45275,975
$38.73-0.69-1.8%$39.25$39.73$38.26188,600
$39.42+0.19+0.5%$39.12$41.58$38.39230,900
$39.23-1.77-4.3%$41.10$41.24$39.04247,100
$41.00+2.19+5.6%$38.88$41.42$38.24388,400
$38.81+2.07+5.6%$36.91$40.10$36.03588,500
$36.74+0.05+0.1%$36.62$37.37$36.06724,700
$36.69+2.69+7.9%$34.54$37.43$34.50976,600
$34.00-0.79-2.3%$34.10$35.51$33.88362,700
$34.79-1.14-3.2%$36.10$36.10$34.44296,800
$35.93-1.29-3.5%$37.26$37.43$34.54491,500
$37.22+2.61+7.5%$35.01$38.50$35.01642,600
$34.61+0.45+1.3%$33.83$35.73$33.13440,700
$34.16-0.10-0.3%$34.02$36.57$34.00385,000
$34.26-0.36-1.0%$35.25$35.59$33.73432,800
$34.62-2.37-6.4%$36.41$36.88$34.47494,500
$36.99-0.29-0.8%$37.72$38.82$36.75388,900
$37.28-1.10-2.9%$38.10$38.59$37.13278,900
$38.38+1.10+3.0%$37.61$39.23$37.34437,200
$37.28-0.61-1.6%$37.89$38.13$36.98713,400
$37.89+0.56+1.5%$37.24$38.17$36.57534,600
$37.33-0.47-1.2%$37.85$38.57$36.99398,900
$37.80-1.39-3.5%$39.13$39.39$37.56413,500
$39.19-3.50-8.2%$42.80$42.80$38.84481,700
$42.69-0.30-0.7%$43.40$43.40$41.21244,400
$42.99+0.52+1.2%$42.55$43.22$41.54310,200
$42.47+0.33+0.8%$42.22$42.54$41.39531,600
$42.14-0.43-1.0%$43.33$43.50$41.78314,500
$42.57-0.47-1.1%$43.37$43.94$42.17231,900
$43.04-1.80-4.0%$44.84$44.84$42.50320,500
$44.84+0.21+0.5%$44.95$45.72$44.55242,800
$44.63-1.62-3.5%$46.80$47.68$44.40208,400
$46.25-1.42-3.0%$47.20$47.20$45.50174,800
$47.67-1.72-3.5%$49.07$49.81$47.46190,100
$49.39+0.05+0.1%$48.53$49.62$47.15301,000
$49.34+1.82+3.8%$47.47$49.91$47.47206,000
$47.52-1.96-4.0%$48.88$48.91$46.72282,500
$49.48+2.38+5.1%$47.31$49.93$46.44518,400
$47.10-0.16-0.3%$47.21$48.21$46.92202,000
$47.26-0.47-1.0%$47.47$47.50$46.38386,900
$47.73-0.16-0.3%$47.64$49.25$46.37230,600
$47.89-0.275-0.6%$48.15$48.42$47.14256,100
$48.17-0.635-1.3%$48.71$48.71$47.21244,900
$48.80+0.59+1.2%$48.70$50.16$48.49217,000
$48.21+0.59+1.2%$47.88$49.06$46.83252,700
$47.62+0.39+0.8%$47.71$48.21$46.34225,800
$47.23-1.71-3.5%$48.51$48.86$46.90194,500
$48.94+0.17+0.3%$49.80$49.97$48.24162,200
$48.77+2.54+5.5%$45.69$48.93$45.69540,300
Ticker
NASDAQ:LBRX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All LB Pharmaceuticals Inc news

Financings

  • Private placement of common stock and pre-funded warrants

    Jul 29, 2026

    Announced: about US$150M · US$34.94 a share · Leerink Partners +1

    Dealers: Leerink Partners, Piper Sandler

    Buyers: Adage Capital Partners, L.P.; BB Biotech; Caligan Partners; Commodore Capital; Deep Track Capital; Farallon Capital Management; Integral Health Asset Management; Janus Henderson Investors; Spruce Street Capital; StemPoint Capital LP

    Use of proceeds: Expand LB-102 into new indications such as negative symptoms of schizophrenia and Alzheimer's agitation/psychosis, plus working capital and general purposes

    Announced Jul 29, 2026

  • Private placement of common stock and pre-funded warrants

    Feb 5, 2026

    Announced: about US$100M · US$21.17 a share · Leerink Partners +2

    Dealers: Leerink Partners, Piper Sandler, Stifel

    Buyers: Balyasny Asset Management L.P.; Caligan Partners; Commodore Capital; Deep Track Capital; Nantahala Capital; Pivotal bioVenture Partners; Spruce Street Capital; TCGX; Trails Edge Capital Partners

    Use of proceeds: Fund a Phase 2 trial of LB-102 as adjunctive treatment for major depressive disorder, plus working capital and general corporate purposes

    Announced Feb 5, 2026

  • Public offering of common stock

    Sep 11, 2025

    Announced: US$285M · US$15 a share · Leerink Partners +2

    Dealers: Leerink Partners (co-lead), Piper Sandler (co-lead), Stifel (co-lead)

    Announced Sep 11, 2025

Read by 6ix AI from the company's releases

Decks

LB Pharmaceuticals Inc on 6ix

Sector
Health care
Industry
Biotechnology
News releases
29 in the last 12 months · 36 in all · newest Nov 5, 2026 · oldest 2025
Decks
16 decks · latest Nov 5, 2026

Where LB Pharmaceuticals Inc is listed

ListingExchangeCountryCurrency
NASDAQ:LBRX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:LBRXBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about LB Pharmaceuticals Inc.